Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.50
-0.01 (-0.66%)
At close: Aug 15, 2025, 2:20 PM
Sunshine Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.13M | -4.23M | -3.68M | -4.09M | -4.51M | -26.77M | -27.57M | -27.21M | -26.74M | -2.57M | -5.15M | -7.49M | -12.44M | -14.19M | -11.12M | -8.87M |
Depreciation & Amortization | 223.51K | 200.47K | 173.04K | 157.05K | 149.14K | 125.77K | 89.36K | 56.76K | 25.16K | 9.37K | 11.76K | 12.67K | 12.74K | 13.12K | 13.44K | 13.42K |
Stock-Based Compensation | 12K | 12K | 12K | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 918K | 918K | 918K | 918K |
Other Working Capital | -3.57M | -4.66M | -3.11M | -879.9K | -94.39K | -685.35K | -705.21K | 506.86K | 276.87K | -79.38K | -90.99K | -79.55K | -2.88K | 25.42K | 16.29K | 10.18K |
Other Non-Cash Items | 2.52M | 4.77M | 2.22M | 3.2M | 1.76M | 20.09M | 20.09M | 18.32M | 18.32M | -914.5K | 2.58M | 4.92M | 10.7M | 12.26M | 9.66M | 7.9M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 3.63K | 3.63K | 3.63K | 3.63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -7.93M | -10.35M | -7.42M | -6.19M | -4.42M | -16.33K | 158.73K | 3.04M | 3.15M | 156.28K | -236.82K | -279.86K | -108.8K | -29.58K | -14.54K | 42.63K |
Operating Cash Flow | -12.53M | -11.81M | -10.91M | -10.11M | -8.78M | -8.33M | -9M | -5.79M | -5.25M | -3.31M | -2.79M | -2.84M | -1.83M | -1.94M | -1.46M | -923.62K |
Capital Expenditures | -2.23M | -2.09M | -1.59M | -1.31M | -788.1K | -789.41K | -777.62K | -483.39K | -305K | n/a | n/a | n/a | n/a | -391 | -1.19K | -1.19K |
Cash Acquisitions | 61.07K | 95.53K | 126.18K | 163.86K | 131.66K | -14.22M | -14.25M | -14.31M | -14.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -754.56K | -1.32M | -1.23M | -1.26M | -622.81K | 27.65K | -842 | 32.09K | -1.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.32M | -2.06M | -1.46M | -1.18M | -656.15K | -15.01M | -56.59M | -56.33M | -56.18M | -41.56M | n/a | n/a | n/a | -391 | -1.19K | -1.19K |
Debt Repayment | 376.52K | -59.27K | -58.87K | -91.26K | -93.13K | -2.19M | -2.16M | -2.13M | -4M | -1.92M | -2.05M | -2.33M | -475.32K | 538.94K | 1.19M | 1.63M |
Common Stock Repurchased | -3.14M | -2.6M | -2.63M | -2.63M | n/a | -640.14K | -605.82K | -605.82K | -198K | -3.42M | -3.42M | -3.42M | -3.32M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.53M | 1.88M | -14.1K | 15.64K | -29.36K | 13.19M | 13.19M | 13.19M | 13.29M | 99K | 99K | 160.5K | 61.5K | -4.49K | -4.49K | -65.99K |
Financial Cash Flow | 9.29M | 7.2M | 5.28M | 9.36M | 3.43M | 1.36M | 42.98M | 68.05M | 81.03M | 83.1M | 42.81M | 14.24M | 2.9M | 3.85M | 3.1M | 2.71M |
Net Cash Flow | -6.61M | -6.64M | -8.22M | -1.86M | -5.53M | -21.71M | -22M | 6.12M | 19.78M | 38.17M | 39.99M | 11.38M | 1.06M | 1.9M | 1.65M | 1.79M |
Free Cash Flow | -14.76M | -13.91M | -12.5M | -11.42M | -9.56M | -9.12M | -9.78M | -6.28M | -5.55M | -3.31M | -2.79M | -2.84M | -1.83M | -1.94M | -1.46M | -924.81K |